Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 27:8:382.
doi: 10.3389/fnhum.2014.00382. eCollection 2014.

Neurorestorative therapy for stroke

Jieli Chen  1 , Poornima Venkat  2 , Alex Zacharek  1 , Michael Chopp  2
Affiliations
Review

Neurorestorative therapy for stroke

Jieli Chen et al. Front Hum Neurosci. .

Abstract

Ischemic stroke is responsible for many deaths and long-term disability world wide. Development of effective therapy has been the target of intense research. Accumulating preclinical literature has shown that substantial functional improvement after stroke can be achieved using subacutely administered cell-based and pharmacological therapies. This review will discuss some of the latest findings on bone marrow-derived mesenchymal stem cells (BMSCs), human umbilical cord blood cells, and off-label use of some pharmacological agents, to promote recovery processes in the sub-acute and chronic phases following stroke. This review paper also focuses on molecular mechanisms underlying the cell-based and pharmacological restorative processes, which enhance angiogenesis, arteriogenesis, neurogenesis, and white matter remodeling following cerebral ischemia as well as an analysis of the interaction/coupling among these restorative events. In addition, the role of microRNAs mediating the intercellular communication between exogenously administered cells and parenchymal cells, and their effects on the regulation of angiogenesis and neuronal progenitor cell proliferation and differentiation, and brain plasticity after stroke are described.

Keywords: BMSC; HUCBC; microRNA; neurorestoration; niaspan.

PubMed Disclaimer

References

    1. Allen C. M. (1984). Predicting the outcome of acute stroke: a prognostic score. J. Neurol. Neurosurg. Psychiatry 47, 475–480 10.1136/jnnp.47.5.475 - DOI - PMC - PubMed
    1. Almici C., Carlo-Stella C., Wagner J. E., Rizzoli V. (1995). Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application. Haematologica 80, 473–479 - PubMed
    1. Andrews E. M., Tsai S. Y., Johnson S. C., Farrer J. R., Wagner J. P., Kopen G. C., et al. (2008). Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp. Neurol. 211, 588–592 10.1016/j.expneurol.2008.02.027 - DOI - PMC - PubMed
    1. Arenillas J. F., Sobrino T., Castillo J., Davalos A. (2007). The role of angiogenesis in damage and recovery from ischemic stroke. Curr. Treat. Options Cardiovasc. Med. 9, 205–212 10.1007/s11936-007-0014-5 - DOI - PubMed
    1. Arien-Zakay H., Lecht S., Nagler A., Lazarovici P. (2011). Neuroprotection by human umbilical cord blood-derived progenitors in ischemic brain injuries. Arch. Ital. Biol. 149, 233–245 10.4449/aib.v149i2.1370 - DOI - PubMed